Nulojix (belatacept) - BMS
Flow Cytometric Immune Profiling Enables Early Detection of Rejection in Islet Xenotransplantation. (PubMed, Xenotransplantation) - Sep 24, 2026 - "Multiplex flow cytometry provides a reliable method for immune monitoring in islet xenotransplantation and may help predict graft rejection." 
Journal • Diabetes • Metabolic Disorders • Transplant Rejection • Transplantation • Type 1 Diabetes Mellitus • CD40LG • CD8
http://www.ncbi.nlm.nih.gov/pubmed/42778262
 
Adwin Thomas; Erin Fuller; Evelyn J Salvaris; Francesco Ierino; Huu Thanh Le; Lauen Joo; Mark B Nottle; Min Hu; Peter J Cowan; Wayne J Hawthorne; Yivee Chew
 
Sep 24, 2026
 
Prev Next